Tourmaline Bio annual meeting elects Castelein and Kantoff as Class I directors, ratifies Deloitte

Tourmaline Bio, Inc.

Dr. Caley Castelein elected with 14,926,508 votes for (2,653,512 withheld); 3,224,245 broker non-votes.
Aaron Kantoff elected with 16,496,989 votes for (1,083,031 withheld); 3,224,245 broker non-votes.
Deloitte & Touche LLP ratified as auditor for FY 2025 with 20,799,312 votes for, 3,257 against, 1,696 abstentions.
Quorum of 20,804,265 shares present out of 25,684,479 shares entitled to vote.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.